Jerry D. Brewer MD, MSProfessor of Dermatology and Program Director, Micrographic Surgery and Cutaneous Oncology, Mayo Clinic, Rochester, Minnesota
Dr. Jerry Brewer has been a member of the Mayo Clinic staff since 2009. Currently, he serves as the Dermatologic Surgery Fellowship program director and is a Professor of Dermatology at the Mayo Clinic College of Medicine. Dr. Brewer’s areas of interest include cutaneous oncology; Mohs micrographic surgery; skin cancer in immunosuppressed patients; laser therapy; vascular surgery (for venous insufficiency); hyperhidrosis; lymphoma associated skin cancer; melanoma epidemiology; Merkel cell carcinoma, and Extra-mammary Paget’s Disease. Dr. Brewer received the Richard K. Winkelmann Research Award in 2008 and the Career Development Award from the Dermatology Foundation in 2009. Dr. Brewer’s research efforts have included the association of lymphoma and skin cancer, skin cancer in transplant recipients, and melanoma epidemiology. Dr. Brewer also received the Karis Award in 2012 by the Saint Marys Hospital Sponsorship Board. Dr. Brewer is the father of 7, and enjoys spending time with family outside of work. In addition, Dr. Brewer’s interests outside of Mayo Clinic include Running (he has participated and successfully completed 4 marathons so far), cooking (and is an avid fan of Bon Appetite Magazine), coaching soccer (which he has done for the past 9 years now) taekwondo (is currently a black belt), and medical humanitarian missions (he has been involved in 3 medical missions to Guatemala so far).
DisclosuresDr. Brewer has no disclosures.
Recent Contributions to PracticeUpdate:
- Value of Mohs Micrographic Surgery for Treating Melanoma and Melanoma in Situ on the Trunk and Extremities
- Survival Outcomes in Patients With Merkel Cell Carcinoma of the Head and Neck Undergoing Mohs Micrographic Surgery vs Wide Local Excision
- Infection and Bleeding Complications in Patients Undergoing Excisional Skin Surgery
- Histologic Margin Status Is an Independent Predictor of Lentigo Maligna Melanoma Progression
- Influence of Perioperative Antiplatelet and Anticoagulant Medication Management on Bleeding Events in Dermatosurgery
- Survival Outcomes After Mohs Micrographic Surgery vs Wide Local Excision in Patients With Merkel Cell Carcinoma
- Prevalence of Wound Complications Following Mohs Micrographic Surgery
- Clinical Factors Impacting Clear Margins of Primary Melanoma in Situ With Conventional Excision
- Intralesional 5-Fluorouracil for Treatment of Non-Melanoma Skin Cancer
- Antibiotic Stewardship for Postoperative Infections in Mohs Surgery